RIGL
NASDAQ · Biotechnology
Rigel Pharmaceuticals Inc
$36.81
-1.25 (-3.28%)
Open$37.63
Previous Close$38.06
Day High$37.83
Day Low$36.14
52W High$52.24
52W Low$24.95
Volume—
Avg Volume322.3K
Market Cap760.46M
P/E Ratio2.09
EPS$18.43
SectorBiotechnology
Analyst Ratings
Buy
11 analysts
Price Target
+47.0% upside
Current
$36.81
$36.81
Target
$54.10
$54.10
$39.68
$54.10 avg
$74.39
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 322.70M | 239.42M | 385.25M |
| Net Income | 402.46M | 268.74M | -63,461,041 |
| Profit Margin | 124.7% | 118.5% | -16.5% |
| EBITDA | 140.23M | 98.84M | -108,813,206 |
| Free Cash Flow | — | — | -71,858,369 |
| Rev Growth | +34.8% | +34.8% | +12.7% |
| Debt/Equity | 0.13 | 0.13 | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |